Do you believe connection is at the heart of healing? Are you looking for a therapist who can help your child use creativity and play to conquer big challenges and learn new skills? Does your child need support in learning emotional regulation skills? Lindsay uses art therapy and her knowledge of neuroscience based therapeutic approaches to help her clients regulate their nervous system, build relational skills, and express themselves safely and authentically through the creative process.
Lindsay’s work is guided by person-centered, humanistic, and psychodynamic counseling theories with a strong neurodevelopmental lens. She utilizes child directed art therapy to provide space for children to use art and imaginative play as a means of symbolic expression and communication. She also uses knowledge of the Expressive Therapies Continuum to guide interaction with art media in order to promote balanced growth and development as well as emotional regulation in her child clients.
Lindsay has worked at Mount Saint Vincent as supervisor to the Creative Arts Therapy team, where she provided services to children and families in Mount Saint Vincent’s residential and day treatment programs. Prior clinical experience also included working as a school and clinic based therapist for Child and Family Services in Fall River, MA and providing art therapy services for the child and adolescent psychiatric hospital at Marillac Children’s Hospital in Overland Park, Kansas. Prior to her clinical experience, Lindsay also worked with children in school and community programs, and with adolescents at a social service agency for arts based job training.
Lindsay is a Licensed Professional Counselor (LPC) and a Provisionally Registered Art Therapist (ATR-P). She is also Phase II (train the trainer) certified in the Neurosequential Model of Therapeutics (NMT). Lindsay received her Master of Science in Art Therapy Counseling from Emporia State University in 2014, and became a licensed counselor in 2017. She completed her Phase I NMT training in 2018, and Phase II in 2020.